The deal comes after Bangladesh said this month it was ready to hold trials of candidate vaccines developed by India as both countries seek to curb the spread of the virus. Beximco will also be the exclusive supplier for Bangladesh for a vaccine developed by the Serum Institute, it said. It is holding trials for three potential coronavirus vaccines, including one licensed to AstraZeneca Plc by Oxford University. Bangladesh also approved a late-stage trial of a potential coronavirus vaccine developed by China's Sinovac Biotech Ltd in the hope of being a priority recipient for the jab. India reported a record daily jump of 77,266 coronavirus infections on Friday, taking its total number of cases to 3.39 million with 61,529 deaths.

Source: bd News24 August 28, 2020 10:41 UTC